Who invested in Kanvas Biosciences?
Kanvas Biosciences's investors include DCVC, Lions Capital, Alumni Ventures, Gaingels and Mana Ventures, and 2 more on record. Lions Capital led its latest round.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$61Mraised across 2 rounds since 2024, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Firms' own news pages and 1 other
From Kanvas Biosciences's own website and the SEC filings it signed: 1 founder, 6 on the team.
On the board, as filediJason PontinPaul Theunissen
AdvisersAditya Bhalla
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Kanvas Biosciences's investors include DCVC, Lions Capital, Alumni Ventures, Gaingels and Mana Ventures, and 2 more on record. Lions Capital led its latest round.
Kanvas Biosciences has raised $61M across 2 rounds since 2024.
Kanvas Biosciences's most recent round was a Series A of $48M in May 2026, led by Lions Capital.
Its most recent round, $48M in May 2026, is also its largest on record.
Kanvas Biosciences's first round on record, in Jul 2024, was backed by DCVC.
Kanvas Biosciences's latest named round is a Series A, in May 2026.
Kanvas Biosciences is based in the United States.
Lions Capital led the Series A in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.